ECU
FLAC

Eisler Capital (UK)’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Eisler Capital (UK)’s Portfolio FLAC Stock Details FLAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-206,429
Closed -$2.04M – 452
2022
Q2 		$2.04M Buy
+206,429
New +$2.04M 0.07% 173

Other funds holding FLAC

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
GL
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

Eisler Capital (UK)'s FLAC Position: Q3 2022 in Review

Eisler Capital (UK) sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q3 2022, closing a stake of 206,429 shares — an estimated $2.04M sold.

Eisler Capital (UK) first reported a position in FLAC in Q2 2022 and held it in 1 quarter. The position peaked at $2.04M in Q2 2022. 52 funds tracked by Wall St. Rank hold FLAC as of Q3 2022.

  • Eisler Capital (UK) reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Eisler Capital (UK) sold 206,429 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q3 2022, an estimated $2.04M.
  • Eisler Capital (UK) first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q2 2022 and held it in 1 quarter.
  • Eisler Capital (UK)'s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $2.04M in Q2 2022.
  • 52 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q3 2022.

Based on Eisler Capital (UK)'s 13F filing for Q3 2022, filed 14 Nov 2022.